Pharmacokinetic interactions of antimalarial agents
- PMID: 11432537
- DOI: 10.2165/00003088-200140050-00003
Pharmacokinetic interactions of antimalarial agents
Abstract
Combination of antimalarial agents has been introduced as a response to widespread drug resistance. The higher number of mutations required to express complete resistance against combinations may retard the further development of resistance. Combination of drugs, especially with the artemisinin drugs, may also offer complete and rapid eradication of the parasite load in symptomatic patients and thus reduce the chance of survival of resistant strains. The advantages of combination therapy should be balanced against the increased chance of drug interactions. During the last decade, much of the pharmacokinetics and metabolic pathways of antimalarial drugs have been elucidated, including the role of the cytochrome P450 (CYP) enzyme complex. Change in protein binding is not a significant cause of interactions between antimalarial agents. CYP3A4 and CYP2C19 are frequently involved in the metabolism of antimalarial agents. Quinidine is a potent inhibitor of CYP2D6, but it appears that this enzyme does not mediate the metabolism of any other antimalarial agent. The new combinations proguanil-atovaquone and chlorproguanil-dapsone do not show significant interactions. CYP2B6 and CYP3A4 are involved in the metabolism of artemisinin and derivatives, but further studies may reveal involvement of more enzymes. Artemisinin may induce CYP2C19. Several artemisinin drugs suffer from auto-induction of the first-pass effect, resulting in a decline of bioavailability after repeated doses. The mechanism of this effect is not yet clear, but induction by other agents cannot be excluded. The combination of artemisinin drugs with mefloquine and the fixed combination artemether-lumefantrine have been studied widely, and no significant drug interactions have been found. The artemisinin drugs will be used at an increasing rate, particularly in combination with other agents. Although clinical studies have so far not shown any significant interactions, drug interactions should be given appropriate attention when other combinations are used.
Similar articles
-
Artemisinin derivatives and malaria: useful, in combination with other antimalarials.Prescrire Int. 2008 Aug;17(96):162-8. Prescrire Int. 2008. PMID: 19492494
-
Clinical pharmacology of artemisinin-based combination therapies.Clin Pharmacokinet. 2008;47(2):91-102. doi: 10.2165/00003088-200847020-00002. Clin Pharmacokinet. 2008. PMID: 18193915 Review.
-
Investigation of pre-clinical pharmacokinetic parameters of atovaquone nanosuspension prepared using a pH-based precipitation method and its pharmacodynamic properties in a novel artemisinin combination.J Glob Antimicrob Resist. 2020 Sep;22:248-256. doi: 10.1016/j.jgar.2020.02.018. Epub 2020 Feb 29. J Glob Antimicrob Resist. 2020. PMID: 32119990
-
Treatment of falciparum malaria in the age of drug resistance.J Postgrad Med. 2006 Oct-Dec;52(4):277-80. J Postgrad Med. 2006. PMID: 17102546 Review.
-
Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.Acta Trop. 2013 May;126(2):150-5. doi: 10.1016/j.actatropica.2013.01.012. Epub 2013 Feb 4. Acta Trop. 2013. PMID: 23391499
Cited by
-
Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.Antimicrob Agents Chemother. 2011 Jun;55(6):2612-22. doi: 10.1128/AAC.01714-10. Epub 2011 Mar 21. Antimicrob Agents Chemother. 2011. PMID: 21422215 Free PMC article.
-
A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs.Malar J. 2009 Dec 9;8:285. doi: 10.1186/1475-2875-8-285. Malar J. 2009. PMID: 20003204 Free PMC article.
-
Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.Clin Pharmacokinet. 2014 Feb;53(2):141-53. doi: 10.1007/s40262-013-0110-5. Clin Pharmacokinet. 2014. PMID: 24158666 Review.
-
Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction.Molecules. 2017 Nov 23;22(12):2049. doi: 10.3390/molecules22122049. Molecules. 2017. PMID: 29168799 Free PMC article.
-
Interaction between tacrolimus and clindamycin.NDT Plus. 2010 Aug;3(4):422-4. doi: 10.1093/ndtplus/sfq090. NDT Plus. 2010. PMID: 25949453 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources